SEC Form 4/A · accession 0001683168-26-005620
PharmaCyte Biotech, Inc. · PMCB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jonathan Schechter
Director
Period of report
Mar 31, 2026
Accepted (ET)
Jul 17, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001157075
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | — | Mar 31, 2026 | J | 0 | A | — | — | Common Stock | — | 0 | D |
Explanation of responses
- F1The reported grant was made in error and has been cancelled.